Caron Treatment Centers Expands Addiction Programs for Adults in Florida Caron Treatment Centers, a nationally recognized nonprofit dedicated to addiction and behavioral healthcare treatment, research, prevention, and education, has announced…
Wheeler Bio Raises $35M in Oversubscribed Series, Plans Expansion Wheeler Bio, a pioneering contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of antibody-based therapies, has…
Lightship Names Darcy Forman as COO to Drive Growth and Efficiency Lightship, a pioneering provider of community-based and decentralized clinical trial services, has announced the appointment of Darcy Forman as…
Valo Health Names Peggy Dalicandro VP, Head of HR Valo Health, Inc. (“Valo”), a pioneering biotechnology company dedicated to revolutionizing the drug discovery and development process through the integration of…
Veracyte Showcases Decipher & MRD Test Insights in Urologic Cancers at EAU25 Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, has announced that eight abstracts highlighting the performance and…
RADIANT Trial Shows Significant Glycemic Gains with Omnipod® 5 After MDI Transition Insulet Corporation (NASDAQ: PODD), a global leader in tubeless insulin pump technology through its Omnipod® brand, has released…
Nexus Pharmaceuticals Expands Portfolio with the Launch of Tranexamic Acid Nexus Pharmaceuticals, LLC has announced the official launch of Tranexamic Acid, marking a significant milestone in the company’s ongoing commitment…
Forth Tx Debuts with Sofinnova’s Support to Transform Fibrosis Treatment Forth Therapeutics (Forth Tx), a biotechnology company pioneering next-generation precision therapeutics for fibrosis, officially launches today with significant backing from…
BioClec Launches to Transform Alzheimer’s Treatment with Sofinnova’s Backing BioClec, a pioneering biotechnology company dedicated to revolutionizing treatments for Alzheimer’s disease, has officially launched. The company emerges from Biovelocita II,…
Sofinnova Partners’ Biotech Fund Exceeds Target at €165M Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm with offices in Paris, London, and Milan, has announced the final…
Protembis Forms Scientific Advisory Board of Leading Heart Experts Protembis, a privately-held cardiovascular medical device company, has announced the establishment of a Scientific Advisory Board (SAB) to provide strategic guidance…
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Covered by Claritev’s National PPO Networks ClearNote Health, a company dedicated to advancing early detection of some of the deadliest cancers, has announced…